FLG and Alzheimer disease: Skin proteomic studies constructed by skin taping and skin biopsy have been extensively performed to check AD biomarkers previously identified from genomics and transcriptomics (e.g., ARG1, KLK5, S100A8, FLG, and SPINKS) [113].